Ciba-Geigy Corporation (United States)

Ciba-Geigy was a major Swiss pharmaceutical company that merged with Sandoz in 1996 to form Novartis. The company developed important treatments in cardiovascular disease, CNS disorders, oncology, and ophthalmology. Ciba-Geigy’s pharmaceutical legacy continues through Novartis’s global leadership in innovative medicines and healthcare solutions.